Looking to publish in Inflammatory Bowel Diseases? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Existing customer loginInflammatory Bowel Diseases publishes original basic science, translational, and clinical research regarding pathogenesis, epidemiology, evaluation, and treatment of IBD that will lead to advancements in overall clinical care.
Looking to publish in Inflammatory Bowel Diseases? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Existing customer loginSubmission Instructions
Inflammatory Bowel Diseases accepts the following article types. Click on an article type to view submission instructions.
Review Articles
Original Articles
Brief Reports
Letters To The Editor
Clinical Practice Guidelines
Recent Publications
Fecal microbiota transplant in the treatment of inflammatory bowel diseases: new perspectives on delivery, mechanism, and clinical positioning
Anum Javed, Despoina Chrysostomou, Julian R Marchesi, Lauren Roberts, Ailsa L Hart, Nick Powell, Horace R T Williams, Lucy C Hicks, Benjamin H Mullish, James L Alexander
Reply to “Risk of serious infection, myocardial infarction, stroke, and thromboembolic events in patients in the United States with ulcerative colitis treated with tofacitinib compared with biologic treatments”
Milena A Gianfrancesco, Jeffrey R Curtis
Endoscopic and histologic healing distribution and persistent rectosigmoiditis in moderate-to-severe ulcerative colitis
Christopher Ma, Jurij Hanzel, Rocio Sedano, F Stephen Laroux, Gregor Novak, Brian Bressler, Hannah Dong, Guangyong Zou, Stefanie C McFarlane, Charles N Bernstein, Neeraj Narula, Rish K Pai, David F Schaeffer, Remo Panaccione, Bruce E Sands, Brian G Feagan, Vipul Jairath
Isolated perianal Crohn disease: the next challenge is long-term surveillance
Deloshaan Subhaharan
Comment on “Clinical and endoscopic features of checkpoint inhibitor-induced colitis and their association with selective immunosuppressive therapy use”
Hui Luo, Jingyuan Li, Ting Ye
Frequently asked questions
How long does it take to publish?
Appeals may take a minimum of 3 to 6 weeks to receive a response from the Editors. Proof corrections must be returned within 48 hours of receipt.
Reformat to Inflammatory Bowel Diseases using Livewrite PremiumIs a cover letter required?
Cover letters are mentioned for disclosure when sharing prior IBD reviews with another journal. Manuscripts posted to a preprint server must be disclosed during submission. AI use should be disclosed in cover letters to editors and in the Methods or Acknowledgements section.
Reformat to Inflammatory Bowel Diseases using Livewrite PremiumWhat are the publication costs?
Subscription journal with open access publishing options available.
Reformat to Inflammatory Bowel Diseases using Livewrite Premium